A439580 Stock Overview
BLUEMTEC Co., Ltd. operates a pharmaceutical distribution platform in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BLUEMTEC Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,350.00 |
| 52 Week High | ₩75,900.00 |
| 52 Week Low | ₩11,640.00 |
| Beta | 0 |
| 1 Month Change | -5.92% |
| 3 Month Change | -26.89% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -73.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| A439580 | KR Healthcare | KR Market | |
|---|---|---|---|
| 7D | 7.6% | -0.9% | 0.6% |
| 1Y | n/a | 20.4% | 6.9% |
Return vs Industry: Insufficient data to determine how A439580 performed against the KR Healthcare industry.
Return vs Market: Insufficient data to determine how A439580 performed against the KR Market.
Price Volatility
| A439580 volatility | |
|---|---|
| A439580 Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A439580's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A439580's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | n/a | bluemtec.com |
BLUEMTEC Co., Ltd. operates a pharmaceutical distribution platform in South Korea and internationally. It is also involved in the healthcare digital marketing, IT development, fulfilment, pharmaceutical distribution data, and medical staff matching, and logistics businesses. The company was founded in 2015 and is headquartered in Yongin, South Korea.
BLUEMTEC Co., Ltd. Fundamentals Summary
| A439580 fundamental statistics | |
|---|---|
| Market cap | ₩145.31b |
| Earnings (TTM) | -₩7.62b |
| Revenue (TTM) | ₩51.87b |
0.0x
P/S Ratio0.0x
P/E RatioIs A439580 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A439580 income statement (TTM) | |
|---|---|
| Revenue | ₩51.87b |
| Cost of Revenue | ₩45.33b |
| Gross Profit | ₩6.54b |
| Other Expenses | ₩14.16b |
| Earnings | -₩7.62b |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A439580 perform over the long term?
See historical performance and comparison